My Account Log in

1 option

Post-neoadjuvant therapy in triple-negative breast cancer (TNBC) / Heather McArthur.

Henry Stewart Biomedical & Life Sciences Collection Available online

View online
Format:
Video
Author/Creator:
McArthur, Heather, (UT Southwestern, USA), Speaker.
Series:
Henry Stewart talks. Biomedical & life sciences collection.
The biomedical & life sciences collection, 2056-452X
Language:
English
Subjects (All):
Breast--Cancer--Adjuvant treatment.
Breast.
Breast--Cancer--Chemotherapy.
Clinical trials.
Breast Neoplasms--drug therapy.
Capecitabine.
Clinical Trials as Topic.
durvalumab.
Antibodies, Monoclonal.
Neoadjuvant Therapy.
olaparib.
olympia.
Gold Alloys.
pembrolizumab.
Antibodies, Monoclonal, Humanized.
Poly(ADP-ribose) Polymerase Inhibitors.
Triple Negative Breast Neoplasms.
Medical Subjects:
Breast Neoplasms--drug therapy.
Capecitabine.
Clinical Trials as Topic.
durvalumab.
Antibodies, Monoclonal.
Neoadjuvant Therapy.
olaparib.
olympia.
Gold Alloys.
pembrolizumab.
Antibodies, Monoclonal, Humanized.
Poly(ADP-ribose) Polymerase Inhibitors.
Triple Negative Breast Neoplasms.
Physical Description:
1 videorecording (18 min., 18 sec.)
Place of Publication:
London : Henry Stewart Talks, 2023.
System Details:
video file
Contents:
Contents: KEYNOTE-522
Pembrolizumab
Clinical trial results
GeparNuevo
Durvalumab
SWOG 1418
IMpassion030
Pathologic complete response
Capecitabine
CREATE-X
OlympiA
Olaparib
Mediola
PARP inhibitors.
Notes:
Description based on publisher supplied metadata and other sources.
Animated audio-visual presentation with synchronized narration.
Title from title frames.
Publisher Number:
5889 Henry Stewart Talks

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account